company

BIO3 AS

6531 AVERØY

Return on Equity
−26,14 %
Current Ratio
1,56
Debt-to-Equity Ratio
1,06
Key figures (NOK)2022
Revenue0
Net Income−982 000
Total Assets10 636 000
Total Equity3 756 000
Income (NOK)2022
Revenue0
Expenditure939 000
Operating Profit−939 000
Financial Income1 000
Financial Costs43 000
Financial Balance−42 000
Earnings Before Tax−982 000
Tax0
Net Income−982 000
Balance (NOK)2022
Total Fixed Assets6 116 000
Total Current Assets4 520 000
Total Assets10 636 000
Total Retained Equity0
Total Equity3 756 000
Total Long-Term Debt3 981 000
Total Current Debt2 899 000
Total Equity and Debt10 636 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure939 000
Operating Profit−939 000
Financial Income1 000
Financial Costs43 000
Financial Balance−42 000
Dividends0
Net Income−982 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets6 116 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets6 116 000
Stock0
Total Investments0
Cash, Bank2 813 000
Total Current Assets4 520 000
Total Assets10 636 000
Total Equity3 756 000
Short-Term Group Debt0
Total Long-Term Debt3 981 000
Creditors702 000
Unpaid Taxes10 000
Dividends0
Other Current Debt2 188 000
Total Current Debt2 899 000
Total Equity and Debt10 636 000
Financial indicators2022
Return on Equity−26,14 %
Debt-to-Equity Ratio1,06
Operating Profit Margin-
Current Ratio1,56
Quick Ratio1,56
Equity Ratio0,35
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English